ERC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Accepted Preprint first posted online on 20 November 2008
Endocrine-Related Cancer (2008) In press
DOI: 10.1677/ERC-08-0150
Copyright © 2008 by the Society for Endocrinology.
This Article
Right arrow Accepted manuscript (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Yang, J.
Right arrow Articles by Han, W.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, J.
Right arrow Articles by Han, W.

RESEARCH

The single-macro domain protein LRP16 is an essential cofactor of androgen receptor

Jie Yang, Yali Zhao, Zhiqiang Wu, Yiling Si, Yuanguang Meng, Xiaobing Fu, Yiming Mu, male and Weidong Han

J Yang, Dept. of Molecular Biology, Chinese PLA General Hospital, Beijing, China
Y Zhao, Dept. of Molecular Biology, Chinese PLA General Hospital, Beijing, China
Z Wu, Dept. of Molecular Biology, Chinese PLA General Hospital, Beijing, China
Y Si, Dept. of Molecular Biology, Chinese PLA General Hospital, Beijing, China
Y Meng, Dept. of Molecular Biology, Chinese PLA General Hospital, Beijing, China
X Fu, Dept. of Molecular Biology, Chinese PLA General Hospital, Beijing, China
Y Mu, Department of Endocrinology, Chinese PLA General Hospital, Beijing, China
W Han, Dept. of Molecular Biology, Chinese PLA General Hospital, Beijing, 100853, China

Correspondence: Weidong Han, Email: hanwdrsw69{at}yahoo.com

Abstract

LRP16 is a special member of the macro domain superfamily, containing only a stand-alone macro domain functional module. Previous study demonstrated that the estrogenically regulated LRP16 cooperates with the estrogen receptor{alpha}and enhances the receptor’s transcriptional activity in an estrogen-dependent manner. Here, we discovered that LRP16 binds to androgen receptor (AR) via its macro domain and amplifies the transactivation function of AR in response to androgen. Similarly, we also discovered that LRP16 acts as a potential coactivator to amplify the transactivation of at least other four nuclear receptors (NRs). Importantly, we show that the single macro domain in LRP16 can serve as the AR coactivator. RNA interference knockdown of LRP16 leads to impaired AR function and greatly attenuates the coactivation of AR by other AR coactivators such as ART-27 and SRC-1. This interference also markedly inhibits the androgen-stimulated proliferation of androgen-sensitive LNCaP prostate cancer cells. However, LRP16 knockdown did not significantly affect the growth rate of AR-negative PC-3 prostate cancer cells. Furthermore, we observed the induction effect of LRP16 expression by androgen and established a feed-forward mechanism that activated AR transactivation. Our results suggest that the macro domain protein LRP16 represents a novel type of cofactor of nuclear receptors. They also indicate that LRP16 plays an essential role in AR transactivation.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the Society for Endocrinology.